tiprankstipranks
Advertisement
Advertisement

HK:3681 Stock Latest News

SinoMab Delays Dispatch of Circular on Major Suzhou Asset Disposal
Company AnnouncementsSinoMab Delays Dispatch of Circular on Major Suzhou Asset Disposal
18h ago
3681
SinoMab Delays Circular on Major Suzhou Property Disposal
PremiumCompany Announcements
SinoMab Delays Circular on Major Suzhou Property Disposal
15d ago
3681
SinoMab Grants 18 Million Share Options to Executive and Staff
PremiumCompany Announcements
SinoMab Grants 18 Million Share Options to Executive and Staff
18d ago
3681
SinoMab to Sell Suzhou Biologics Facility in RMB280 Million Deal
PremiumCompany Announcements
SinoMab to Sell Suzhou Biologics Facility in RMB280 Million Deal
1M ago
3681
SinoMab Elevates COO Fang Liang to Executive Director to Bolster Biotech Strategy
PremiumCompany Announcements
SinoMab Elevates COO Fang Liang to Executive Director to Bolster Biotech Strategy
1M ago
3681
SinoMab BioScience Clarifies Board and Committee Structure
PremiumCompany AnnouncementsSinoMab BioScience Clarifies Board and Committee Structure
1M ago
3681
SinoMab Bioscience Clarifies Board Structure and Committee Roles
Premium
Company Announcements
SinoMab Bioscience Clarifies Board Structure and Committee Roles
2M ago
3681
SinoMab Shareholders Unanimously Approve All Resolutions, Add New Non-Executive Director
Premium
Company Announcements
SinoMab Shareholders Unanimously Approve All Resolutions, Add New Non-Executive Director
2M ago
3681
SinoMab Showcases Promising Preclinical Data for Novel Antibody in Alopecia and Vitiligo
PremiumCompany Announcements
SinoMab Showcases Promising Preclinical Data for Novel Antibody in Alopecia and Vitiligo
3M ago
3681
SinoMab Sets 2026 AGM to Renew Board, Auditor and Share Capital Mandates
PremiumCompany Announcements
SinoMab Sets 2026 AGM to Renew Board, Auditor and Share Capital Mandates
4M ago
3681
SinoMab Starts Phase 2 Trial of IL‑25 Antibody SM17 in Chinese Atopic Dermatitis Patients
PremiumCompany Announcements
SinoMab Starts Phase 2 Trial of IL‑25 Antibody SM17 in Chinese Atopic Dermatitis Patients
4M ago
3681
SinoMab Updates Board and Committee Structure to Clarify Governance Roles
PremiumCompany Announcements
SinoMab Updates Board and Committee Structure to Clarify Governance Roles
4M ago
3681
SinoMab BioScience Announces Resignations of Two Non-Executive Directors
PremiumCompany AnnouncementsSinoMab BioScience Announces Resignations of Two Non-Executive Directors
4M ago
3681
SinoMab Bioscience Sets Out Board and Committee Structure
Premium
Company Announcements
SinoMab Bioscience Sets Out Board and Committee Structure
4M ago
3681
SinoMab Reports Positive Phase 1 Data for Subcutaneous SM17 in China
Premium
Company Announcements
SinoMab Reports Positive Phase 1 Data for Subcutaneous SM17 in China
5M ago
3681
SinoMab Grants 11.6 Million Share Options to Key Employees
PremiumCompany Announcements
SinoMab Grants 11.6 Million Share Options to Key Employees
5M ago
3681
SinoMab Narrows Loss as Key Antibody Programs Advance and Funding Base Expands
PremiumCompany Announcements
SinoMab Narrows Loss as Key Antibody Programs Advance and Funding Base Expands
5M ago
3681
SinoMab Ends Haikou Lease as It Shifts to Asset-Light Manufacturing Model
PremiumCompany Announcements
SinoMab Ends Haikou Lease as It Shifts to Asset-Light Manufacturing Model
5M ago
3681
SinoMab BioScience Sets March Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
SinoMab BioScience Sets March Board Meeting to Approve 2025 Annual Results
5M ago
3681
SinoMab’s New SM17 Trial Puts Atopic Dermatitis Back in Focus for HK:3681 Investors
PremiumCompany AnnouncementsSinoMab’s New SM17 Trial Puts Atopic Dermatitis Back in Focus for HK:3681 Investors
5M ago
3681
SinoMab Wins China IND Nod to Expand SM17 Into Inflammatory Bowel Disease
Premium
Company Announcements
SinoMab Wins China IND Nod to Expand SM17 Into Inflammatory Bowel Disease
6M ago
3681
SinoMab’s SM17 IND Application for IBD Accepted by NMPA
Premium
Company Announcements
SinoMab’s SM17 IND Application for IBD Accepted by NMPA
8M ago
3681

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >